Ten gears after the foundation of a national diabetic eye screening pr
ogram in 1980, we have established a low prevalence of blindness and p
artial sight in type 1 and type 2 diabetics in Iceland, We ask whether
the screening program is also associated with a low incidence of blin
dness in diabetics. We now report the results of a prospective study o
n the 4-year incidence of diabetic retinopathy and visual impairment i
n type 1 diabetics with age at onset less than 30 years, Out of 205 pa
tients participating at baseline, 175 patients (85.4%) participated ov
er the fun 4-year period, Patients were examined annually and received
laser treatment according to Diabetic- and Early Treatment Diabetic R
etinopathy Study criteria, The 4-year incidence of any retinopathy was
38.1%, of proliferative retinopathy 6.6%, and of macular edema 3.4%,
Out of 174 patients, 7.4% showed improvement in visual acuity of 2 Sne
llen lines while 2.5% experienced worsening of visual acuity of 2 Snel
len lines during the 4-year period, No diabetic suffered more than 2 l
ines deterioration of vision and none became legally blind, The incide
nce of retinopathy in Icelandic type I diabetics participating in our
annual eye screening program is low and the visual acuity stable, Our
results suggest that visual impairment in diabetics can be prevented w
ith active regular screening and standard laser therapy.